Company Filing History:
Years Active: 2008
Title: Marcel Morvan: Innovator in Neuropsychiatry
Introduction
Marcel Morvan, an accomplished inventor based in PACE, France, has made significant contributions to the field of neuropsychiatry through his innovative work with ary piperaszine derivatives. His research focuses on compounds that have the potential to be transformative in treating various mental health conditions.
Latest Patents
Morvan holds a patent for the invention of ary piperaszine derivatives, which are compounds identified through a specific general formula. This patent encompasses the process for producing these compounds and their application as therapeutic agents. The selective ligands for the dopamine D3 receptor that he has discovered are particularly beneficial in the treatment of psychotic and depressive states, as well as motor disorders like dyskinesia and essential tremor. Furthermore, these innovations hold promise in addressing dependencies on substances such as nicotine, cocaine, alcohol, and opioids, thereby facilitating withdrawal in drug-dependent individuals.
Career Highlights
Marcel Morvan is associated with Bioprojet, a company dedicated to advancing therapeutic solutions. His work at Bioprojet reflects a commitment to developing innovative treatments that enhance patient care in the field of neuropsychiatry. Morvan's patent not only showcases his ingenuity but also emphasizes the importance of research and innovation in tackling complex health issues.
Collaborations
Throughout his career, Morvan has collaborated with notable colleagues, including Marc Capet and Denis Danvy. These partnerships highlight the collaborative spirit of research, allowing for the exchange of ideas and fostering innovation within the scientific community.
Conclusion
Marcel Morvan's contributions, exemplified by his patent for ary piperaszine derivatives, underscore his role as a key innovator in neuropsychiatry. His work at Bioprojet, along with collaborative efforts with other experts, reflects a dedication to improving treatments for mental health conditions. As such, Morvan continues to be an influential figure in the realm of therapeutic innovation.